VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRVO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRVOCervoMed Inc.
$3.15$29M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCRVOQuarterly Financials

CervoMed Inc. (CRVO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

CervoMed Inc. (CRVO) quarterly income statement — complete revenue, gross profit & net income history

CRVO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00322.57K00000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00322.57K00000000000000000
Gross Margin %--100%-----------------
Gross Profit Growth %--------------------
Operating Expenses8.11M8.33M8.37M6.62M5.3M7.24M5.4M3M2.59M2.48M2.68M1.23M1.43M4.25M904.05K4.25M4.55M3.47M12.69M3.83M
OpEx % of Revenue--2593.79%-----------------
Selling, General & Admin2.98M2.51M2.33M3.27M2.38M2.32M2.21M2.51M2.13M2.12M2.41M992.55K1M2.34M573.51K2.14M2.13M1.93M1.93M1.84M
SG&A % of Revenue--721.19%-----------------
Research & Development5.14M5.83M6.04M5.11M4.84M7.09M5.13M3.77M2.81M2.86M1.79M1.96M1.83M1.9M330.54K2.11M2.43M1.5M2.11M1.97M
R&D % of Revenue--1872.6%-----------------
Other Operating Expenses0-8.73K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K000026.11K1000K23.75K
Operating Income-8.11M-8.33M-8.04M-6.62M-5.3M-7.24M-5.4M-3M-2.59M-2.48M-2.68M-1.23M-1.43M-4.25M-904.05K-4.25M-4.55M-3.47M-12.69M-3.83M
Operating Margin %---2493.79%-----------------
Operating Income Growth %-52.95%-15.06%-49.07%-120.9%-104.35%-191.92%-101.72%-143.31%-81.93%41.62%-195.9%71.01%68.68%-22.6%92.88%-10.77%2.77%15.21%-140.68%-4.78%
EBITDA-8.11M-8.33M-7.73M-6.62M-5.3M-7.24M-5.4M-3M-2.59M3.16M-2.68M-1.23M-1.43M-4.25M-904.05K-4.25M-4.55M-3.44M-12.67M-3.81M
EBITDA Margin %---2395.34%-----------------
EBITDA Growth %-52.95%-15.06%-43.18%-120.9%-104.35%-329.1%-101.72%-143.31%-81.93%174.39%-195.9%71.01%68.68%-23.53%92.87%-11.46%2.26%15.33%-141.43%-4.9%
D&A (Non-Cash Add-back)0000000000000000026.11K19.1K23.75K
EBIT-8.11M-8.33M-7.73M-6.62M-5.3M-7.24M-5.4M-3M-2.59M3.16M-2.68M-1.23M-1.43M-4.25M-904.05K-4.25M-4.55M-3.47M-4.05M-3.83M
Net Interest Income147.39K240.94K318.79K368.13K408.99K532.18K646.17K678.44K80.63K118.65K47.67K17.71K35.4K172.85K21.52K55.38K27.81K-8.87K50.71K55.23K
Interest Income147.39K240.94K318.79K368.13K408.99K532.18K646.17K678.44K80.63K118.65K47.67K17.71K35.4K172.85K21.52K55.38K27.81K050.71K55.23K
Interest Expense000000000000000008.87K00
Other Income/Expense146.37K244.23K317.56K357.87K408.85K534.91K642.73K678.19K80.6K118.05K4.83M-194.5K891.98K172.85K21.43K55.38K27.81K-8.87K50.71K55.23K
Pretax Income-7.96M-8.09M-7.73M-6.26M-4.89M-6.71M-4.75M-2.32M-2.51M-2.36M2.15M-1.43M-534.34K-4.08M-882.62K-4.19M-4.53M-3.47M-12.64M-3.78M
Pretax Margin %---2395.34%-----------------
Income Tax000000000000000000-443.89K0
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%3.51%0%
Net Income-7.96M-8.09M-7.73M-6.26M-4.89M-6.71M-4.75M-2.32M-2.51M-2.36M2.15M-1.43M-534.34K-4.08M-882.62K-4.19M-4.53M-3.47M-12.2M-3.78M
Net Margin %---2395.34%-----------------
Net Income Growth %-62.73%-20.6%-62.54%-170.12%-94.65%-183.86%-321.06%-62.53%-370.55%42.04%343.63%65.98%88.2%-17.31%92.77%-10.92%2.53%14.47%-174.81%-20.89%
Net Income (Continuing)-7.96M-8.09M-7.73M-6.26M-4.89M-6.71M-4.75M-2.32M-2.51M-2.36M2.15M-1.43M-534.34K-4.08M-882.62K-4.19M-4.53M-3.47M-12.2M-3.78M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.86-0.87-0.84-0.70-0.56-0.77-0.55-0.27-0.41-0.42-0.70-1.55-3.01-3.00-1.70-3.08-3.33-2.56-8.98-2.78
EPS Growth %-53.57%-12.99%-52.73%-159.26%-36.59%-83.33%21.43%82.58%86.38%86%58.82%49.68%9.61%-17.19%81.07%-10.79%20.9%46.2%-72.69%62.02%
EPS (Basic)-0.86-0.87-0.84-0.70-0.56-0.77-0.55-0.27-0.41-0.420.65-1.55-3.01-3.00-1.70-3.08-3.33-2.56-8.98-2.78
Diluted Shares Outstanding9.26M9.25M9.25M8.95M8.7M8.7M8.7M8.7M6.17M5.67M3.77M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.36M
Basic Shares Outstanding9.26M9.25M9.25M8.95M8.7M8.7M8.7M8.7M6.17M5.67M3.31M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.36M1.36M
Dividend Payout Ratio--------------------